Clindamycin Phosphate recalls

6 recalls on record

Recalled by 1 agency: FDA (6).

First recall on record: January 21, 2026. Most recent: September 9, 2026.

Risk classification: Class II: 5 · Class III: 1

Recalert records 6 recalls for Clindamycin Phosphate from FDA. The earliest is dated January 21, 2026 and the latest September 9, 2026. 6 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50. (D-0808-2026).

Most recent recalls

Questions about this brand

Does Clindamycin Phosphate have recalls in 2026?
Recalert records 6 recalls for Clindamycin Phosphate dated in 2026.

Do you sell Clindamycin Phosphate products? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related brands